Carolina Infusion, LLC recalls TIRZEPATIDE 26 MG/ML INJECTABLE
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
- Products
-
- TIRZEPATIDE 26 MG/ML INJECTABLE
- Company
- Carolina Infusion, LLC
- Where it was sold
-
Nationwide within the U.S
Nationwide
- Units affected
- 5.6 mLs - in patient specific syringe doses
- About this recall
- TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;